© 2020 PROSPER TRADING ACADEMY, LLC | All Rights Reserved IMPORTANT NOTICE: Stock and Stock Options trading involves a substantial degree of risk and may not be suitable for all investors. Past performance is not necessarily indicative of future results. Prosper Trading Academy LLC provides only training and educational information. By visiting the website and accessing our content, you are agreeing to the terms and conditions.
Trading successfully is all about finding the right picks and balancing risk with reward. It takes skill, experience and determination. Charlie has put in a ton of work to simplify all of that in this guide. It is a quick read and you will learn something. Things are changing in the market, and you don't want to be left behind. If you're not aware of what I'm covering in this quick 5 minute video, you're risking more than you think. The chance to re-watch a presentation that could literally change your life don't come by every often, so do yourself a favor… Turn off any distractions, and check it out Talk soon, Charlie "big things are coming" Moon. Position your portfolio for the rising odds of President Trump's re-election, according to JPMorgan Chase & Co. (JPM), which says the spread between him and challenger Joe Biden is now nearly even. That's largely due to the impact on public opinion of violence around protests, as well as potential bias in polls, said strategist Marko Kolanovic. "Implications could be significant for the performance of factors, sectors, COVID-19 winners/losers, as well as ESG, though certainly a lot can happen in the next ~60 days. "Our Take: If anyone thought that this election was going to be a cakewalk for either candidate, you would be sorely mistaken. We have not seen the last plot twist in this saga.Phase 3 Trials Start AstraZeneca (AZN) is starting Phase 3 trials of its experimental coronavirus vaccine in the U.S., becoming the third company to start late-stage trials to prevent COVID-19.Trial centers across the nation are recruiting up to 30K adults aged 18 years or over. AstraZeneca's vaccine, known as AZD1222, was developed in partnership with Oxford University and has the backing of the U.S. government. Rivals Moderna (MRNA) Pfizer (PFE)/BioNTec (BNTX) already have Phase 3 trials under way, also with federal funding. Our Take: Who will come out ahead in this race-to-finish competition for a much-needed treatment/preventative measure for COVID-19? There is a ton of pressure from the administration to be able to claim victory over the virus. Walmart+ the Answer to Prime? Walmart (WMT) is finally going head to head with Amazon (AMZN) via a nationwide membership program, though the retailer says the new service is "really about doubling down with the customers we have and getting more share of wallet and more share of mind. "The program, which costs $98 annually, or $12.95 a month, will launch on Sept. 15. Biggest difference: Walmart+ customers will have to spend a minimum of $35 for each online order to avoid fees, while rival Amazon Prime touts free two-day (and some same-day) shipping on every item. Our Take: Recently, Walmart has proven that it has the motivation to take on world-beater Amazon. Look at the ambition with the Microsoft partnership to bid for Tik Tok. If anyone can get in the ring with Amazon, it is Walmart. The Stock Tracker by Charlie MoonThe markets refusal to go down is leading buyers to keep pushing the all time highs trade.As in buy the top tick and worry about it later. Why not when stocks and stock markets refuse to drop? This is a great risk on environment, but expect the pullback to take place soon. It may only last a day or two but at least we can finally buy something on sale for once. Other Names To Watch: WKHS, NIO, JD, PTON, DOCU The Options Corner by Mike Shorr & Scott Bauer The VIX continues to have a POSITIVE beta to stocks. This almost never happens. The market is trying to tell you something. Take the hint and don't get caught overexposed to the upside. On the Earnings Front: HRB (AMC)GSX (tomorrow BMO)LE (tomorrow BMO)M (tomorrow BMO),Stocks To Watch: Bullish: ATVI, MTCH, ROST, STNE Bearish: AMAT, DAL, OSTK
| 
No comments:
Post a Comment
Keep a civil tongue.